• Return to Headlines

Genomic Health I Up 26.3% Since SmarTrend Uptrend Call (GHDX)

By James Quinn

SmarTrend identified an Uptrend for Genomic Health I (NASDAQ:GHDX) on July 1st, 2019 at $58.61. In approximately 2 month, Genomic Health I has returned 26.35% as of today's recent price of $74.06.

Over the past year, Genomic Health I has traded in a range of $50.77 to $92.18 and is now at $74.06, 46% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 2.1%.

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The Company's diagnostic services provide information on the likelihood of disease recurrence and response to certain types of therapy.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Genomic Health I shares.

Log in and add Genomic Health I (GHDX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights genomic health i

Ticker(s): GHDX